Pfizer, Drug Companies Must Face Price-Fixing Suit

Lock
This article is for subscribers only.

Pfizer Inc., the world’s largest drugmaker, and other drug companies must face a price-fixing suit claiming they conspired to keep cheaper medicines from Canada out of the U.S. market.

The California Supreme Court today reversed a lower court, which two years ago granted dismissal of the suit by allowing the companies to use a “pass-on” defense. The companies argued they couldn’t be held liable for illegal drug overcharges -- and that the pharmacies weren’t harmed -- because any overcharge was passed on to consumers.